Eibhlin Mulroe at Joint Oireachtas Committee

Extract from presentation by Eibhlin Mulroe to the Joint Oireachtas Committee on Health on 13th March 2019.

“Due to our reduced funding, we have had to decline opening clinically important academic trials in Ireland. These trials would benefit people with a range of cancers including lymphoma, testicular and endometrial cancer. We are unable to be proactive in exploring opportunities to open new trials in areas such as pancreatic, lung, testicular and cervical cancer. This is as a direct result of reduced funding.”